Evolus (EOLS) Research & Development (2017 - 2026)
Evolus (EOLS) posted Research & Development of $1.97 million for Q3 2026, down 3.8% from $2.05 million a year earlier but up 4.0% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Research & Development at Evolus was $9.58 million, up 12.4% year-over-year; for FY2025, it was $9.58 million, up 4.4% from FY2024.
- Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 40.9% (FY2020 to FY2025).
- In prior years, Evolus' Research & Development was $9.17 million in FY2024 (+39.9%), $6.56 million in FY2023 (+38.3%), $4.74 million in FY2022 (+129.7%) and $2.06 million in FY2021 (+19.9%).
- Quarterly Research & Development has run from a low of $423,000 in Q4 2021 to a high of $3.48 million in Q4 2025 over five years.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 2.4%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2022, with growth of 357.1%; the weakest was Q1 2022, with a decline of 44.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $1.89 million (Q2 2026), $2.24 million (Q1 2026) and $3.48 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | 1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.97 Mn |
| Jun 30, 2026 | 1.89 Mn |
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 468,000.00 |
| Dec 31, 2021 | 423,000.00 |
API Access
Evolus Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();